ADSK
70
-4
NKE
31
-2
AIV
60
-4
SYK
71
-2
CI
48
-4
STX
50
-2
LRCX
48
2
MA
65
-2
GD
46
-13
GOOG
65
-4
RRC
58
-2
BWA
53
-2
AIG
44
-3
ILMN
42
-3
CSX
62
-6
UNH
60
-3
SRE
63
-3
DVN
21
-8
O
30
-3
AAL
59
2
ADSK
70
-4
NKE
31
-2
AIV
60
-4
SYK
71
-2
CI
48
-4
STX
50
-2
LRCX
48
2
MA
65
-2
GD
46
-13
GOOG
65
-4
RRC
58
-2
BWA
53
-2
AIG
44
-3
ILMN
42
-3
CSX
62
-6
UNH
60
-3
SRE
63
-3
DVN
21
-8
O
30
-3
AAL
59
2
Financhill
Back

Editas Medicine Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
43

EDIT
Editas Medicine

Last Price:
2.67
Seasonality Move:
16.26%
Sell
42

APLS
Apellis Pharmaceuticals

Last Price:
26.26
Seasonality Move:
20.78%
Sell
43
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $2.77. The Score for EDIT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $28.06. The Score for APLS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $2.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $28.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 38.08 Sell
Chaikin Money Flow: -1545182 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.95 - 3.37) Sell
Bollinger Bands (100): (3.16 - 4.84) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.24 Sell
Relative Strength Index (14 RSI): 45.18 Sell
Chaikin Money Flow: -2912738 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.06 - 28.78) Buy
Bollinger Bands (100): (29.25 - 39.19) Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.1 Sell
20-day SMA: 3.14 Sell
50-day SMA: 3.35 Sell
200-day SMA: 5.35 Sell
8-day EMA: 3.03 Sell
20-day EMA: 3.12 Sell
50-day EMA: 3.4 Sell
200-day EMA: 5.13 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.85 Sell
20-day SMA: 28.04 Buy
50-day SMA: 30.45 Sell
200-day SMA: 43.48 Sell
8-day EMA: 28.61 Sell
20-day EMA: 28.52 Sell
50-day EMA: 30.4 Sell
200-day EMA: 40.17 Sell

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $0.23 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):